Gainers
- OS Therapies (AMEX:OSTX) shares rose 57.9% to $6.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $139.5 million.
- Helius Medical Tech (NASDAQ:HSDT) shares rose 24.29% to $0.86. The company's market cap stands at $3.2 million.
- Quantum-Si (NASDAQ:QSI) shares rose 18.71% to $2.41. The company's market cap stands at $381.5 million.
- Lexaria Bioscience (NASDAQ:LEXX) stock moved upwards by 15.54% to $2.23. The market value of their outstanding shares is at $39.1 million. The company's, Q1 earnings came out 3 days ago.
- MetaVia (NASDAQ:MTVA) stock increased by 14.63% to $2.34. The company's market cap stands at $20.1 million.
- AlloVir (NASDAQ:ALVR) shares increased by 13.74% to $0.46. The company's market cap stands at $52.5 million.
Losers
- Aclarion (NASDAQ:ACON) stock fell 48.8% to $0.05 during Wednesday's pre-market session.
- Anitra (AMEX:AZTR) shares decreased by 32.17% to $0.29. The market value of their outstanding shares is at $2.1 million.
- GlucoTrack (NASDAQ:GCTK) stock fell 27.63% to $0.09. The market value of their outstanding shares is at $1.4 million.
- Keros Therapeutics (NASDAQ:KROS) stock fell 19.8% to $10.01. The company's market cap stands at $405.4 million.
- Phio Pharma (NASDAQ:PHIO) shares fell 17.04% to $2.97. The market value of their outstanding shares is at $5.1 million.
- Ardent Health Partners (NYSE:ARDT) shares declined by 14.52% to $12.01. The company's market cap stands at $1.7 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ARDTArdent Health Inc
$14.052.86%
AZTRAzitra Inc
Not Available-%
GCTKGlucoTrack Inc
$5.40-2.88%
HSDTSolana Co
$5.07-5.76%
KROSKeros Therapeutics Inc
$16.90-0.82%
LEXXLexaria Bioscience Corp
$1.08-2.70%
MTVAMetaVia Inc
$0.7361-7.99%
OSTXOS Therapies Inc
$1.88-3.09%
PHIOPhio Pharmaceuticals Corp
$1.613.87%
QSIQuantum-Si Inc
$1.58-0.91%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
